| Grams | Price | Price/Grams | |
|---|---|---|---|
| 5 | €68.00 | €13.6 | Buy Now |
| 10 | €113.00 | €11.3 | Buy Now |
| 25 | €240.00 | €9.6 | Buy Now |
| 50 | €405.00 | €8.1 | Buy Now |
| 100 | €690.00 | €6.9 | Buy Now |
FUB-AMB (also known as AMB-FUBINACA and MMB-FUBINACA) is an indazole-based synthetic cannabinoid that is a potent agonist for the cannabinoid CB1 and CB2 receptors. It was originally developed by Pfizer which described the compound in a patent in 2009, but was later abandoned and never tested on humans.
Cas No: 1715016-76-4
Formula: C21H22FN3O3
IUPAC:
Appearance:
Purity: